Jazz Pharmaceuticals plc — Director's Dealing 2012

Mar 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2012-03-09

Reporting Person: ENRIGHT PATRICK G (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-09	Ordinary Shares	S	49985	$49.56	Disposed	0	Direct
2012-03-09	Ordinary Shares	S	1078400	$49.56	Disposed	1748990	Indirect
2012-03-09	Ordinary Shares	S	21615	$49.56	Disposed	35052	Indirect

Footnotes

F1: Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of Jazz Pharmaceuticals, Inc. held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P., except to the extent of his pecuniary interest therein.